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Executive summary
This is the twenty-third annual report of the
Volatile Substance Abuse (VSA) Mortality
Project, and has been produced by the
International Centre for Drug Policy (ICDP)
based at St. George’s, University of London.
This report outlines the current trends,
examines the nature of the problems, and
identifies the factors associated with deaths
from abuse of volatile substances occurring in
the United Kingdom in 2008.
There were 36 deaths associated with volatile
substance abuse in 2008, bringing the
cumulative total of VSA deaths in the UK since
1971 to 2,343. Since 1992 there has been a
significant fall in deaths which appears to have
decreased further in recent years. During the
last decade (1999-2008), age at death ranged
from 7 to 85 years (mean = 28, SD 13.3), and
one-third of deaths occurred in the under-20
years age-group. Eighty percent of deaths
were male, and in 2008 deaths from volatile
substance abuse accounted for 0.5% of all-
cause deaths in males aged 15-19 years.
Standard Mortality Ratios (SMRs) differed
significantly across countries and Government
Office Regions in England: the highest SMR
was in Northern Ireland (193) and the lowest in
the North West region of England (70). Gas
fuels continue to be associated with the
majority of deaths; over 90% in 2008. A steady
decrease in suicides associated with the
inhalation of a volatile substance was observed
during the last ten-year period. However, it is
worth noting that this fall appears to have been
off-set by a rapid increase in suicides involving
the inhalation of helium. As for VSA deaths in
general, the majority (56%) of suicides involved
males.
Volatile substance abuse remains an important
problem in the UK, especially in terms of
causing premature death amongst young
people. This challenging issue, therefore, needs
to be addressed through substance abuse
education programmes and other initiatives, as
well as examination of appropriate preventative
measures and treatment provision, if required.
Key findings for deaths in 2008:
 There were 36 deaths associated with
volatile substance abuse in 2008, bringing
the total number of VSA deaths in the UK
since 1971 to 2,343.
 Since 1992 there has been a significant
fall in deaths, from an average of 77 per
year in 1992-1999, to an average of 54 per
year in 2000-2008.
 Gas fuels continue to be associated with
the majority of deaths. In 2008, butane
from all sources, including aerosol
propellants, accounted for 83% of VSA
deaths (30 out of 36 deaths).
 In under-18 year olds there were five VSA
deaths in 2008 compared with eight in
2007 and seven in 2006. Of these five
deaths, two were associated with butane
cigarette lighter refills, the sale of which to
under-18s is prohibited by legislation, and
three were associated with aerosols.
 VSA deaths overall continue to be more
common among males than females. In
2008, there were 34 deaths among males
as compared to only two deaths among
females, although in under-18 year olds
this ratio was 3:2.
 Of the 36 deaths in 2008, four were
suicides in males involving the inhalation
of a volatile substance. Of these four
deaths, three were of adults - one of whom
was aged 85.
 In 2008 there were two deaths (three in
2007) associated with the inhalation of
nitrous oxide, which had been obtained for
non-medical purposes.
 Although, as an inert gas, helium is not a
volatile substance, previous reports have
provided some basic information on this
gas. The number of helium-related deaths
has risen since 2001, but at an increasing
rate in the last two years, standing at 25 in
2008. During this period the majority
(89%) of cases were suicides. The
majority of deaths were among males,
those aged 20-59 years, and caused by
asphyxia (including plastic bag over head).
VSA
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Introduction
Volatile Substance Abuse (VSA) has been a
global issue for several decades according to
the World Health Organisation (1993), though
the substances are not usually considered to
be illegal. In contrast to the situation with
respect to illicit drugs, in most countries there
is little or no criminal involvement in the supply
of products used for VSA. Compounds such
as diethyl ether, chloroform and nitrous oxide
have been deliberately inhaled for recreational
purposes since the early 1800s. Many of the
substances which have been abused by
inhalation remain in widespread use.
The first modern reports of VSA started to
appear in the 1950s (Ramsey et al, 1989),
involving petrol, glues and solvent-based
thinning agents, initially in the United States,
and then Western Europe, particularly
Scandinavia. Volatile substance use is not
automatically linked to gender, race or class,
the substance abuse is often a group activity
and peer-group influence may be a factor in
encouraging the persistence of the practice
(Flanagan et al, 1997). Abuse of volatile
substances is an issue that can affect anyone,
anywhere.
For example, research indicates that the main
issues underlying volatile substance abuse for
indigenous youth in inner Brisbane, Australia,
include: unstable living situations, lack of
involvement with school, low levels of
meaningful activity and boredom, existence of
a substance-using peer group, lack of
belonging to a culture, and high levels of
mental health concerns (Butt, 2004). The
results of the 2008 National Survey on Drug
Use and Health in the USA show that there
was a significant decrease in the average age
at first use among recent inhalant initiates
aged 12 to 49 from 2007 (17.1 years) to 2008
(15.9 years (Substance Abuse and Mental
Health Services Administration, 2009).
Another study conducted among young Native
Indians in the USA indicates that the typical
user of these substances is an adolescent
male with low self-esteem and a family
background of alcoholism and physical
aggression (Howard et al, 1999). In the 2004
Canadian Addiction Survey, the majority of
individuals (67%) reported first using inhalants
between 12 and 16 years of age; 13% used
before the age of 12 and 19% at age 17 or
older (Adlaf et al, 2005).
In the UK there was a steady increase in VSA
deaths from the early 1960s onwards, with
deaths peaking in the early 1990s at over 150
per year (Field-Smith et al, 2004),
Data from the Office for National Statistics
reveal that the trends in prevalence and death
from VSA continue to be serious substance-
related issues, certainly for the younger
teenage population in the UK (Harris, 2006).
According to the National Advisory Committee
on Drug (NACD) survey conducted in the
Republic of Ireland in 2006/07, the proportion
of the adult population who reported using a
solvent or volatile inhalant in their lifetime was
higher and more common for men than
women (National Advisory Committee on
Drugs and Drug and Alcohol Information and
Research Unit, 2008).
The monitoring of deaths from deliberate
inhalation of volatile substances is made
difficult by the variety of substances abused,
the various modes by which death may occur,
and the lack of an appropriate code under the
International Classification of Diseases
(Anderson, 1990). In addition, international data
collection systems on VSA vary from country to
country. For example, a systematic information
collection programme on inhalant-related
deaths in the USA has been maintained by the
North Carolina Office of the Chief Medical
Examiner (Hall et al, 2010), another
retrospective study of inhalant deaths
collected information from autopsy
examinations reported since 1983 by the
Office of Forensic Science in South Australia
(Wick et al, 2007).
Information on all ascertained deaths
associated with VSA in the UK was
systematically collected by the Division of
Community Health Sciences at St. George’s
University of London from 1983. Research by
that team demonstrated that knowledge of,
and interest in, the problem had grown, and
there had probably been a real increase in the
number of deaths (Anderson et al, 1985).
Various efforts have been made to prevent
solvent abuse and reduce the risk of
premature death among abusers. Many of
these attempts, however, do not affect the
scale of the problems, the pattern of
substances abused, or the risk of accidental
death among those abusing volatile
substances. The most notable exception was
the Department of Health’s advertising
campaign in February 1992 aimed at parents;
VSA
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this led to a fall from an all-time peak of 152
deaths in 1990 to 67 in 1994.
Last year’s report noted that gas fuels
continue to be associated with the majority of
deaths, both for adults and children. In
particular, the single product of butane gas
lighter refills is responsible for over one-third of
deaths and volatile substance abuse which led
to death, usually in the home (Field-Smith et
al, 2009).
This report is an annual statistical summary of
data on trends in deaths associated with the
deliberate inhalation of volatile substances. It
has been produced by the International Centre
for Drug Policy (ICDP) at St. George’s,
University of London, which took over
responsibility for this work from 2009. Data for
deaths occurring in 2008 are analysed in this
report, together with updated information for
earlier years. Therefore, this report supersedes
all previous ones.
There is a necessary delay of more than twelve
months between the end of a calendar year and
publication of the annual report. This is to allow
time for details to become available from HM
Coroners and from the Office for National
Statistics (ONS), and the General Register
Offices for Scotland and Northern Ireland.
This report is intended to inform policy-making
and service provision at local and national
level. It may also be of interest to health
professionals, academics, and other stake-
holders.
Definitions
The terms ‘glue sniffing’ and ‘solvent abuse’,
which were commonly used in connection with
the abuse of volatile substances, have for some
years been inadequate to describe the problem,
hence the adoption of the term ‘Volatile
Substance Abuse’ or ‘VSA’. Other terms widely
used are ‘inhalant abuse’ and ‘huffing’. VSA has
been defined by this project since 1983 as: “the
deliberate inhalation of a volatile substance
(gas, aerosol propellants, solvents in glue and
other solvents) to achieve a change in mental
state”.
Solvents are a diverse group of substances
whose chemical vapours can be inhaled to
produce psychoactive or mind-altering effects
(National Institute on Drug Abuse. (2007).
Descriptions and examples of the most
commonly abused substances are given in the
Appendix. Inhaled volatiles produce a similar
effect to hypnotics/sedatives or ethanol with
euphoria and distortion of consciousness being
experienced within seconds from a low dosage
(Flanagan and Ives, 1994; Steffee et al, 1996).
Death may occur from the direct toxic effects
of the inhaled substances or from trauma.
Fatalities often occur very quickly, and there is
usually no opportunity to intervene medically
and thus to prevent death. Mortality associated
with the abuse of volatile substances is related
to many factors, including the chemical nature of
the substance itself, the product containing it,
the method of inhalation and the prevalence of
abuse.
In this report, in the context of volatile
substance abuse, the term ‘substance’ is used
to denote the generic category within which
‘products’ are grouped. Thus, for example, the
aerosol ’substance’ includes ‘products’ such
as deodorants, air fresheners, and fly sprays.
Methods and procedures
The historic dataset includes cases where there
is no direct toxicological proof, but circumstantial
evidence of varying grades suggesting that
these deaths were associated with volatile
substance abuse. The data also include
suicides where a volatile substance was
deliberately inhaled. All such cases are coded
accordingly so that they can be reviewed if
necessary. When further cases or additional
data for previous years come to notice they are
added to the dataset. For example, this report
contains one additional case for both of the
years 2004 and 2007. Deaths can also be
removed from the dataset if subsequent
information puts them outside the case criteria.
In 2008, there were 38 deaths ascertained
initially, but two were later excluded from
analysis after receipt of autopsy and
toxicological reports and discussions with
relevant pathologists and forensic toxicologists.
VSA
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The project employs both active and passive
case-ascertainment approaches. The active
approach involves: the use of press-clipping
services, Google and other Internet searches of
regional and national newspapers, as well as
other media sources, to identify cases. Regular
visits are made to the Medical Toxicology
Laboratory at Guy’s and St Thomas’ Hospital
Trust, and the Forensic Toxicology Service at St
George’s, University of London, and a number
of coroners’ offices to check their records for
possible cases. For the passive approach,
information on deaths associated with VSA in
England and Wales is provided by HM
Coroners. For Scotland, information is supplied
by the Crown Office and the General Register
Office for Scotland. Details of Northern Ireland
deaths are provided by the State Pathologist’s
Department, the Coroners Service for Northern
Ireland, and the Northern Ireland Statistics &
Research Agency on behalf of the General
Register Office for Northern Ireland. The Deputy
Viscount in Jersey, HM Greffier in Guernsey,
and the High Bailiff in the Isle of Man supply
information for their areas. Data on ‘all-cause’
mortality and population estimates are supplied
by the Office for National Statistics, the General
Register Office for Scotland and the Northern
Ireland Statistics & Research Agency.
To enable comparison with various national
and international datasets all causes of death
have been coded according to the
International Classification of Diseases version
10. This is an international standard for the
classification of diseases and health-related
problems published by the World Health
Organisation. The current on-line (2007)
version is employed by this Project (World
Health Organization, 2007).
The method of data collection used by this
project has been stable and systematic since
1983. The process of confirming cause of
death is undertaken by reference to the case
definition criteria; each case is critically
checked against information provided by the
Coroner or Procurator Fiscal, including
toxicological information, autopsy reports,
incident reports or witness statements, and
other documents.
Information from these sources is entered into
coding sheets by two separate team members
and any discrepancies reconciled, before
being entered into the database. Death
associated with VSA in 2008 and deaths
occurring in any previous years have been
added to the historic dataset. All data held,
whether electronic or paper, is stored securely
and treated as confidential. Access is
restricted to project staff; only aggregated and
anonymous data are released to third parties
and only with the prior written consent of the
relevant data-provider.
For some analyses all deaths have been used.
For examining time trends, the period of stable
data collection has been used (1983-2008),
whilst for others the most recent ten-year period
has been employed.
This report has been produced following
analysis of all available information in a
cumulatively updated database. Data-cleaning
for a separate research project indicated that
some relevant cases had been omitted and
other non-relevant cases included in the
historic database. As a result, a few of the
numbers for some earlier years may be
different to those previously published.
All tables have designed using uni- and bi-
variate tabulation formats, and related
graphs/charts have also been drawn up using
these tables. Statistical analysis was
undertaken using SPSS™ for Windows
version 17 (based on the previous EPI Info
and Stata® programs) and Stata® for Windows
version 9. The presentation of complex
statistical techniques has been kept to a
minimum to facilitate ease of reading.
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Trends in total VSA deaths
The total number of deaths between 1971 and
2008 was 2,343; during 2008 there were 36
deaths. Figure 1 gives the total number of
deaths from 1983, when the methods of data
collection became stable and systematic, to
2008. The Figure shows that there was a steady
increase between 1985 and 1991 followed by a
more gradual decline.
A commonly-used technique is ‘smoothing’
which, when properly applied, reveals more
clearly the underlying trend. The ‘moving
average’ method is one of these techniques,
which can smooth a data-series and make it
easier to spot trends. It is routinely employed
with time-series data to smooth out short-term
fluctuations and highlight longer-term trends.
In Figure 2, the three-year moving average
method was used to examine the underlying
trend in VSA deaths for all ages between 1983
and 2008.
An increasing upward trend in deaths is
discernible during the 1980s, followed by a
sharper decline in the early 1990s. This was
followed by a period of stability, with a more
gradual fall from the late 1990s. The decline
since the peak around 1990 reflects the impact
of the publicity campaign by the Department of
Health in 1992. There are no noteworthy
variations between 1997 and 1999 as well as
in later periods, when the average number
ranges from about 50 to 75 deaths per year.
There has been a continuing programme of
health education, along with personal and
social education in schools, addressing the
issue of volatile substance abuse. Guidance
has been published on how to approach this
within the National Curriculum (Department for
Education and Skills, 2004; Stradling et al,
2009).
Figure 1: VSA deaths for all ages, by year,
1983 to 2008 (n=2,129)
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Figure 2: Trends in VSA deaths for all ages, 1983-2008
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Death by age
Table 1 presents the age-distribution of VSA
deaths in 1971-98 and during the last 10
years. In 2008 the youngest person to die was
aged 12 years and the oldest was aged 85
years. This Table also shows that the fall in
deaths since 1971 was predominantly among
adolescents (<15 years) with a gradual decline
among older teenagers (15-19 years). Just
under half (46.6%) of VSA deaths occurred in
the under-20 years age-group during the early
part of this decade, falling to 20% in recent
times. The proportion of deaths accounted for
by adults (20 years and over) remained stable
until about 2005. Since that time, this proportion
has increased significantly.
Changes in the age-distribution are illustrated
in several ways, e.g. those aged 15-19 years
have been declining, whereas those aged 30
years or more have seen a sharp increase and
those aged 25-29 years have remained stable.
However, the proportion of teenagers and
youths are more likely than those in other age-
groups in the general population to die from
abuse of volatile substances. Figure 3 shows a
larger proportion of deaths among teenagers
(10-14 years) and youths (15-19 years) as
compared to their counterparts in both historic
data (1971-2007) and in 2008. This Figure
also shows a shift in the distribution of deaths
towards higher age-groups, when 2008 is
compared with historic data. This shift is highly
statistically significant (p<0.001 in the Mann-
Whitney U test where all deaths were
included).
VSA
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Table 1: Age-distribution (%) of VSA deaths, 1971-98 and each year to 2008
Year
Age Group
(years)
1971-
98
99 00 01 02 03 04 05 06 07 08
All
1971-
08
7 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1
9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
10 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2
11 0.3 1.3 0.0 0.0 1.5 0.0 0.0 2.2 0.0 0.0 0.0 0.4
12 1.3 1.3 4.5 0.0 3.1 1.9 2.1 0.0 0.0 0.0 2.8 1.4
13 3.4 1.3 0.0 3.2 7.7 0.0 4.2 0.0 0.0 0.0 0.0 3.0
14 9.4 4.0 3.0 7.9 6.2 3.7 0.0 6.5 2.0 0.0 0.0 8.0
15 14.0 5.3 9.1 7.9 9.2 1.9 10.4 4.3 5.9 0.0 0.0 12.0
16 13.9 5.3 4.5 14.3 6.2 3.7 6.3 0.0 2.0 6.8 8.3 12.0
17 10.6 14.7 4.5 6.3 3.1 5.6 4.2 4.3 3.9 6.8 2.8 9.5
18 8.2 9.3 6.1 9.5 6.2 0.0 4.2 2.2 5.9 3.4 5.6 7.6
19 5.4 0.0 9.1 6.3 4.6 5.6 6.3 2.2 2.0 1.7 2.8 5.1
20-24 15.7 13.3 16.7 12.7 15.4 24.1 10.4 17.4 7.8 13.6 19.4 15.5
25-29 7.9 13.3 9.1 6.3 6.2 14.8 2.1 19.6 11.8 13.6 8.3 8.5
30-39 5.1 16.0 21.2 14.3 16.9 27.8 31.3 23.9 35.3 35.6 27.8 9.6
40-49 2.0 9.3 4.5 6.3 6.2 5.6 8.3 4.3 11.8 10.2 11.1 3.4
50-59 1.6 1.3 6.1 3.2 6.2 3.7 8.3 8.7 5.9 3.4 5.6 2.4
60-69 0.7 1.3 0.0 1.6 1.5 0.0 2.1 4.3 3.9 1.7 0.0 0.9
70+ 0.1 2.7 1.5 0.0 0.0 0.0 0.0 0.0 2.0 3.4 5.6 0.4
Total 1780 75 66 63 65 54 48 46 51 59 36 2343
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Figure 3: Age-distribution of VSA deaths,
1971-2007 & 2008
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Death in young people (10-19 years)
Figures 4 and 5 show the mortality rates per
million populations for each year from 1999 to
2008, respectively for the 10-14 years and 15-
19 years age-groups by gender. These rates
were calculated by taking into account any
possible changes over time in the general
population. In both age-groups the mortality
rates for females are generally lower than
those for males. A few exceptions were
observed in the 10-14 years age-group.
Table 2 presents a comparison of deaths from
VSA, from drug misuse (defined as deaths
where the underlying causes is poisoning, drug
abuse or dependence and where any of the
substance controlled under the Misuse of Drugs
Act 1971 are involved), from transport accidents
and from all causes among the 10-14 and 15-19
years age-groups in the UK for 2008. Mortality
data for all causes, transport accidents and
drug misuse are for deaths registered in 2008,
whereas those for VSA are those occurring in
the calendar year.
In 2008 there was only one death in the 10-14
years age-group, but at the 15-19 years age-
group VSA deaths accounted for 0.5% of deaths
from all causes. In the same year, transport
accidents (which are by far the most frequent
cause of death), accounted for 13.7% of all
deaths at age 10-14 years and 29.4% of all
deaths at age 15-19 years. Deaths associated
with drug misuse accounted for 1.6% of all
deaths in the 10-14 years age-group and 4.7%
of all deaths in the 15-19 years age-group.
Looking more closely at individual age data for
England and Wales for 2000 to 2008, the ratio
of VSA to drug misuse deaths appears to cross
over between the ages of 14 and 15 years. In
the 10-14 year age-group there were 34 VSA
deaths over the nine-year period compared with
15 deaths related to drug misuse. In the same
period, at age 15 years there were 28 VSA
deaths and 34 deaths related to drug misuse. At
age 16 years there were 29 VSA deaths and 64
deaths related to drug misuse. It should be
noted that all drug misuse death numbers are
collated by registration year and that in England
and Wales, VSA deaths coded to ICD 10: F18
where an illicit drug is mentioned on the death
record are also included in the drug-related
deaths.
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Figure 4: VSA mortality rates for ages 10-14 years by
gender, 1999-2008
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Figure 5: VSA mortality rates for ages 15-19 years by
gender, 1999-2008
Males
Females
Table 2: Number of deaths in the UK for the 10-14 and 15-19 years age-
groups, by cause of death, 2008
Age (years)
10-14 15-19
Cause of death
No. % of all
causes
No. % of all
causes
All causes*
Male
Female
218
161
57.5
42.5
955
430
69.0
31.1
Total 379 100.0 1385 100.0
Transport accidents*
Male
Female
34
18
15.6
11.2
307
100
32.2
23.3
Total 52 13.7 407 29.4
Drug misuse*$
Total 6 1.6 65 4.7
Volatile Substance Abuse
Male
Female
1
0
0.5
0.0
5
2
0.5
0.5
Total 1 0.3 7 0.5
* Deaths registered in 2008. $ Data on drug misuse by gender were not available.
Sources of data for death from all causes, transport accidents and drug misuse:
England and Wales: Office for National Statistics
Scotland: General Register Office for Scotland
Northern Ireland: Northern Ireland Statistics and Research Agency for GRONI
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Death by gender
Table 3 shows the gender-distribution of deaths
associated with volatile substances. In 2008
only two female deaths were recorded (6%)
while male deaths numbered 34 (94%). Over
the past ten years males have accounted for an
average of 85% of deaths across all age-
groups. There have been slight year-to-year
fluctuations in this proportion.
Figures 6 and 7 shows the percentage of deaths
among males and females aged under 18 years
and in persons aged 18 years and over
respectively, for 1971-1998 and each year to
2008. In 2008 there were five deaths (two
female) in the under-18 year age-group
(Figure 6); there were 31 deaths (all male) in
the 18 years and over age-group (Figure 7).
To compare the difference in proportions of
males and females in the two age-groups, a
statistical test was employed (Chi-square test)
which shows marked gender differences
(X2=17.1, 1df, p<0.001) in both those aged
under-18 and aged 18 and above. Again, over
time there have also been significant
differences in gender for both those aged
under 18 years and for those aged 18 years
and over. This shows a significantly lower
proportion of females to males were observed
over time in both age-groups.
Figure 5 shows a higher percentage of deaths
for males compared to a lower percentage for
female. A survey of secondary schoolchildren
aged 11-15 years in England in 2008 was
carried out for the National Centre for Social
Research and the National Foundation for
Educational Research. This found that 4.8% of
male pupils in this age-range used volatile
substances in the 12 months prior to the
survey compared to 5.2% of female pupils
(Fuller, 2009). The European School Survey
Project on Alcohol and other Drugs (ESPAD)
2007 found that there was no gender
difference in lifetime inhalant use among 16-
year olds in the majority of countries surveyed,
although a gender difference was evident for
the UK (Hibell et al, 2009). Although there is
greater use of volatile substances by girls, the
number of deaths is higher amongst boys.
This indicates that boys are at higher risk of
dying from VSA.
Table 3: Gender-distribution of VSA deaths, 1971-1998 & each year to 2008
Gender
Male Female All persons
Year
No. % No. % No. %
1971-98 1547 86.9 233 13.1 1780 100.0
1999 67 89.3 8 10.7 75 100.0
2000 54 81.8 12 18.2 66 100.0
2001 49 77.8 14 22.2 63 100.0
2002 49 75.4 16 24.6 65 100.0
2003 39 72.2 15 27.8 54 100.0
2004 39 81.3 9 18.8 48 100.0
2005 35 76.1 11 23.9 46 100.0
2006 38 74.5 13 25.5 51 100.0
2007 49 83.1 10 16.9 59 100.0
2008 34 94.4 2 5.6 36 100.0
Total 2000 85.4 343 14.6 2343 100.0
VSA
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Figure 6: Gender-distribution of VSA deaths by age (<18
years), 1971-98 and each year to 2008
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Figure 7: Gender-distribution of VSA deaths by age (18+
years), 1971-98 and each year to 2008
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Regional variation
Table 4 shows the numbers of deaths by
country and by Government Office Region in
England. In 2008, there were 29 deaths in
England, two in both Wales and Northern
Ireland, and three deaths in Scotland. There
were no deaths in the Channel Islands or Isle of
Man.
Table 5 and Figure 9 give the Standardised
Mortality Ratios (SMRs) for each Region and
country averaged across the period 1999-2008.
SMRs are used to compare geographical
areas taking account of any differences in the
age- and gender-distribution of the population.
The whole of the UK has an average SMR of
100. Countries and regions where the SMR is
higher than 100 have more deaths than
expected and those where the SMR is less
than 100 have lower deaths than expected.
SMRs differ significantly across countries and
Government Office Regions (P< 0.001 with 11
df.). For the period 1999–2008 Northern
Ireland had the highest SMR (193) and North
West England had the lowest SMR (70). In
general, there were more deaths than
expected in Northern Ireland, Scotland, Wales,
North East, Yorkshire and Humber, and the
East and West Midlands. London, South East
and South West exhibited lower death rates
than expected.
Table 4: Number of VSA deaths by Government Office Region (England) and
Country, 1971-98 and each year to 2008
YearRegion or Country
71-98 99 00 01 02 03 04 05 06 07 08
Total
England:
North East 112 7 3 3 6 4 1 2 2 3 1 144
North West 236 6 10 4 4 5 6 1 3 2 4 281
Yorkshire/Humber 167 5 5 10 7 4 6 4 4 5 3 220
East Midlands 115 6 5 9 5 3 7 6 4 6 2 168
West Midlands 156 7 7 5 10 5 3 3 5 7 5 213
East 113 4 7 5 2 4 4 4 5 5 2 155
London 216 7 4 6 2 8 6 8 4 5 5 271
South East 179 4 7 4 10 8 5 7 5 8 4 241
South West 102 8 4 3 5 1 3 1 2 3 3 135
Total England 1396 54 52 49 51 42 41 36 34 44 29 1828
WALES 70 7 1 1 5 1 4 1 5 2 2 99
SCOTLAND 242 8 9 9 8 6 1 4 9 10 3 309
N. IRELAND 64 6 2 4 1 5 2 5 3 3 2 97
CHANNEL ISLANDS 6 0 1 0 0 0 0 0 0 0 0 7
ISLE OF MAN 2 0 1 0 0 0 0 0 0 0 0 3
Total UK and Island 1780 75 66 63 65 54 48 46 51 59 36 2343
VSA
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Table 5: Standardised Mortality Ratios for Govt. Office Region (England)
and Country, adjusted for age and gender, 1999-2008
DeathsRegion or Country
Observed Expected
SMR 95% confidence
interval
ENGLAND
North East 32 23.8 135 92 to 190
North West 45 64.0 70 51 to 94
Yorkshire/Humber 53 47.6 111 83 to 146
East Midlands 53 39.9 133 100 to 177
West Midlands 57 50.0 114 86 to 148
East 42 50.0 84 60 to 113
London 55 77.1 71 54 to 93
South East 62 75.0 83 63 to 106
South West 33 44.8 74 51 to 144
Total England 432 472.1 92
WALES 29 26.7 109 73 to 156
SCOTLAND 67 47.1 142 110 to 181
N. IRELAND 33 17.1 193 133 to 271
Total UK* 561 561 100
Crude Mortality Rates per
million population per year
Male = 1.55 Female = 0.36 All persons = 0.94
* Channel Isles and Isle of Man are not included
Sources of population data (Average of censuses updated mid-year estimates for 2003 and 2004)
England and Wales: Office for National Statistics
Scotland: General Register Office for Scotland
Northern Ireland: Northern Ireland Statistics and Research Agency for GRONI
VSA
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Figure 8: Standardised Mortality Ratios for Govt. Office Region (England)
and Country, adjusted for age and gender, 1999-2008
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Substances abused
The main substances abused by all age-groups
between 1999 and 2008 are shown in Table 6.
Butane intended for fuel use and butane used
as a propellant in aerosols are classified
separately. The highest proportion of deaths is
associated with only one volatile substance -
butane. In 12 (2%) deaths over this 10-year
period, two volatile substances in combination
were known to be involved. Table 6 and Figure
9 show the number of times each substance
was associated with death.
Over the time-period 1971 to 2008 there was a
notable change in the proportions of specific
substances abused. In 2008 the total number of
cases associated with gas fuels was 26, lower
than in any of the previous nine years (even
taking into account a fall in the absolute number
of such deaths between 2007 (41deaths) and
2008 (23 fatalities). The declines in aerosol-
related deaths in recent years and declines in
glue-related deaths over time are more
pronounced.
Figure 10 gives the same information for those
aged less than 18 years for the number of times
each substance was associated with death.
Changes in the proportion of substances
abused in this age-group are also notable, with
marked fluctuations observed in different
periods between 1999 and 2008. In 2008
deaths associated with gas fuels sharply
declined as compared to 2007; whereas deaths
associated with aerosols moved in the opposite
direction.
Table 6: Substance abused, all ages, each year 1999 to 2008 (n=2454*)
YearSubstance
1971 -
98
99 00 01 02 03 04 05 06 07 08
Total
Gas fuels 795 50 38 47 46 38 34 29 28 42 26 1173
% 42.3 66.7 56.7 72.3 70.8 69.1 69.4 63.0 54.9 66.7 66.7 47.8
Aerosols 346 10 13 12 10 6 5 8 7 6 4 428
% 18.4 13.3 19.4 18.5 15.4 10.9 10.2 17.4 13.7 9.5 10.3 17.4
Glues 318 5 7 4 3 4 5 2 1 1 0 350
% 16.9 6.7 10.4 6.2 4.6 7.3 10.2 4.3 2.0 1.6 0.0 14.3
Other 351 9 8 1 6 7 5 7 15 12 8 438
% 18.7 12.0 11.9 1.5 9.2 12.7 10.2 15.2 29.4 19.0 20.5 17.5
Fire
Extinguishers
57 1 0 0 0 0 0 0 0 0 0 58
% 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4
Not known 12 0 1 0 0 0 0 0 0 1 1 15
% 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.6 0.6
All substances 1879 75 67 65 65 55 49 46 51 63 39 2454
* Number of substances is greater than the number of deaths as all substances associated with a death are included.
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Figure 9: Substance associated with fatal abuse, all ages,
1999-2008 (n=575*)
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* All substances associated with a death are included.
Figure 10: Substance associated with fatal abuse, under
18 years of age, 1999-2008 (n=146*)
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* All substances associated with a death are included.
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Products abused
Table 7 shows products abused by substance
for 2008. This also gives the type of products
implicated in death, showing them as
percentages of substances used, rather than as
percentages of the total number of deaths.
There were no multiple product fatalities in
2008. However, in previous years there were
some instances of more than one product being
involved and thus deaths can appear more than
once in the table. Butane gas lighter fuel was
associated with 25% of all substances fatally
abused in 2008. In addition, unspecified
butane (including butane gas can), some of
which is likely to have been lighter fuel,
accounted for another 23% of all substances
in the same year.
In 2008 there were two deaths (four in 2007)
associated with the inhalation of anaesthetic
agents. Both cases involved nitrous oxide,
supplied for non-medical use as cylinders or
as caplets designed to be employed with
cream-whipping devices, and were the result
of asphyxiation where the nitrous oxide had
been inhaled using a plastic bag over the
head. The supply, other than by a registered
pharmacist, of nitrous oxide for inhalation is an
offence under Section 52 of the Medicines Act
1968. In addition two deaths were associated
with the inhalation of chloroform and three
deaths involved the inhalation of alkyl nitrites
(‘poppers’). The supply of chloroform and one
form of alkyl nitrite, isobutyl nitrite, is now
controlled by legislation, The Dangerous
Substances and Preparations (Safety)
Regulations 2006, which came into full effect
in August 2007. In 2008 there was one death
involving the use of paint thinner but none
involving the use of products like insect spray
or petrol (while there was one for each
category in 2007).
Table 8 gives similar information for the period
1971 to 2008. This shows the wide variety of
products that has been abused within the broad
substance categories. Since 1971, butane gas
lighter fuel has been associated with a little
higher than 80% of fatal abuses of gas fuel, and
38% of all substances fatally abused.
Deodorants and anti-perspirants have been
associated with 46% of fatal abuses of aerosols,
and 8% of all substances, and contact
adhesives with 54% of fatal abuses of glue, also
8% of all substances. Since 1995 there have
been no deaths from text-correction fluid or
pain-relief sprays and only one death from a
fire extinguisher (involving an old product).
Table 9 shows deaths associated with butane
cigarette lighter refills in the time-period 1971-
1998 and for each year from 1999 to 2008 by
gender for those aged under-18 years of age.
Amongst those in this age-group, there were
two deaths in 2008, compared with 3 in 2007
and 2 in both 2006 and 2005. Legislation
which banned the sale of these items to under-
18 year olds came into effect in October 1999
[The Cigarette Lighter Refill (Safety)
Regulations 1999]. In this age-group the
number of deaths associated with lighter fuel
fell from an average of 18 per year between
1991 and 1999 to 7 per year between 2000
and 2008. The difference between these two
periods is statistically significant (X2=21.6, 1df,
p<0.001). About two-thirds (61%) of the fall in
deaths occurred after the coming into force of
these regulatory provisions. These changes
provide evidence to suggest that the change in
legislation had some beneficial impact.
However, detailed analysis will be needed to
evaluate the impact of changes in legislation
over time.
The coming into force of a European Union
Directive (2005/95/EC) which restricted the
use of toluene and trichlorobenzene in
products harmful to man and the environment
on 15 December 2006, together with the
introduction of the first phase of provisions on
1 January 2007 of the Volatile Organic
Compounds (VOCs) in Paints, Varnishes and
Vehicle Refinishing Products Regulations
2005 may have contributed to the low level in
recent years of deaths involving the deliberate
inhalation of products containing these
substances.
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Table 7: Substance abused, by product, 2008 (n=36*)
Substance and product No. % of substance
group
% of all
substances
GAS FUELS
Lighter fuel 9 42.8 25.0
Calor gas/domestic gas 3 14.3 8.3
Propane 1 4.8 2.8
Butane gas can 1 4.8 2.8
Butane unspecified 7 33.3 19.4
TOTAL OF GAS FUELS 21 100.0 58.3
AEROSOLS
Deodorant 5 100.0 13.9
TOTAL OF AEROSOLS 5 100.0 13.9
OTHER
Chloroform 2 25.0 5.6
Alkyl nitrites 3 37.5 8.3
Paint thinners 1 12.5 2.7
Nitrous oxide (anaesthetic) 2 25.0 5.6
Total of Other 8 100.0 22.2
Substance not known 2 100.0 5.6
All Substances 36 - 100.0
* No multiple substances associated with a death
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Table 8: Substance abused, by product, 1971-2008 (n=2,446)
Substance and product No. % of substance
group
% of all
substances
Lighter fuel 940 80.4 38.4
Calor gas/domestic Gas 113 9.7 4.6
Propane 37 3.2 1.5
Acetylene 3 0.3 0.1
Butane gas can 45 3.8 1.8
Butane Unspecified 31 2.7 1.3
TOTAL OF GAS FUELS 1169 100.0 47.8
Deodorant 200 46.3 8.2
Pain relief spray 63 14.6 2.6
Air freshener 51 11.8 2.1
Hair spray 33 7.6 1.3
Cleaning fluid 17 3.9 0.7
Fly spray 8 1.9 0.3
Paint spray 8 1.9 0.3
Aerosol glue 2 0.5 0.1
Other aerosols 50 11.6 2.0
TOTAL OF AEROSOLS 432 100.0 17.7
Contact adhesive 186 53.8 7.6
Puncture repair glue 11 3.2 0.4
Model glue 3 0.9 0.1
Other glues 146 42.2 6.0
TOTAL OF GLUES 346 100.0 14.1
Typewriter correction fluid 112 26.4 4.6
Chloroform 40 9.4 1.6
Unspecified trichloroethylene 38 8.9 1.6
Petrol 38 8.9 1.6
Paint thinners 15 3.5 0.6
Domestic cleaner-unspecified 19 4.5 0.8
Industrial solvent 18 4.2 0.7
Carbon tetrachloride 12 2.8 0.5
Nitromors paint stripper 6 1.4 0.2
Alkyl nitrites 21 4.9 0.9
Refrigerant gases 5 1.2 0.2
Ether 5 1.2 0.2
Benzene 1 0.2 0.0
Nitrous oxide (anaesthetic) 47 11.1 1.9
Misc other 48 11.3 2.0
TOTAL OF OTHERS 425 100.0 17.4
Fire Extinguishers 58 100.0 2.4
Substance not known 16 100.0 0.7
TOTAL OF ALL SUBSTANCES 2446 100.0 100.0
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Table 9: Deaths associated with cigarette lighter refills, 1971-1998 and each
year to 2008
YearGender
71-98 99 00 01 02 03 04 05 06 07 08
Total
Male 318 15 7 12 13 4 6 1 2 2 2 382
Female 59 0 1 3 2 2 2 1 0 1 0 71
All persons 377 15 8 15 15 6 8 2 2 3 2 453
VSA deaths (All) 949 25 17 25 24 10 13 8 7 8 5 1091
% all VSA deaths 39.7 60.0 47.1 60.0 62.5 60.0 61.5 25.0 28.6 37.5 40.0 41.5
Other psychoactive substances associated with VSA deaths
Figure 11 shows that other psychoactive
substances, including alcohol, were also
present in the post mortem toxicology of VSA
fatalities. This does not mean that they
necessarily caused, or contributed to, death.
Drugs were mentioned in 25 (69%) cases in
2008 and 34 (58%) cases in 2007. In 2008,
alcohol (as a sole additional substance) was
recorded in 25% of cases, followed by illicit
drugs (21%) and hypnotic drugs (16%). On the
other hand, hypnotics/sedatives such as
benzodiazepines as sole additional
substances were mentioned in 28% of cases
in 2007, followed by illicit drugs (19%) and
alcohol (18%). The presence of methadone
was also evident in both years: 12% in 2007,
and 7% in 2008. These findings underline the
continuing emergence of polysubstance
abuse. Combining the use of psychoactive
substances increases the risk of overdose and
death (Ghodse et al, 2009).
Figure 11: VSA deaths with other psychoactive substances
at post mortem, 2007 and 2008
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Method of administration
Methods of administration of volatile
substances are given in Tables 10; Table 11
gives this information by product. Over the last
ten years, the highest proportion of deaths
occurred after substances were discharged
directly into the mouth, followed by substances
sniffed from plastic bags. The predominant
method of abuse of butane lighter refills is
believed to be by discharge directly into the
mouth. In the absence of evidence to the
contrary, lighter fuel abuse has been coded to
this method. The most common method of
administration for aerosols has been by
spraying through a cloth, and for glues has
been by inhalation of the fumes or vapours
from plastic bags.
Table 10: Methods of administration of main substances, 1971-1998 and
each year to 2008
PeriodMethod
1971-98 99 00 01 02 03 04 05 06 07 08
Total
Directly into mouth 488 30 31 40 34 34 25 18 27 31 20 778
Sniffed from container 128 4 4 1 7 6 5 4 2 3 2 166
Sniffed from cloth or sleeve 182 3 5 7 8 4 2 3 4 2 5 225
Sniffed from plastic bag 284 9 3 3 3 1 2 0 1 0 2 308
Plastic bag over head 197 8 10 3 7 5 10 12 13 15 2 282
Mask or padding over face 44 3 2 2 1 1 3 5 3 7 3 74
Other 23 1 0 0 0 0 0 0 0 0 1 25
Not known 434 17 11 7 5 3 1 4 1 1 1 485
Total 1780 75 66 63 65 54 48 46 51 59 36 2343
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Table 11: Methods of administration of main substances, by product, 1971-
1998 and each year to 2008 (n=2343)
PeriodSubstance and method
1971-98 99 00 01 02 03 04 05 06 07 08
Total
Gas fuels
Directly into mouth 423 29 31 40 34 33 25 15 22 30 19 701
Sniffed from container 24 1 2 1 2 0 1 1 0 0 1 23
Sniffed from cloth or sleeves 13 0 0 0 1 0 0 0 0 1 0 15
Sniffed from plastic bag 40 2 1 0 0 0 1 0 0 0 1 45
Plastic bag over head 83 5 3 3 6 4 5 8 5 10 0 132
Mask or padding over face 14 2 0 1 1 0 1 3 1 0 0 23
Other 9 1 0 0 0 0 0 0 0 0 1 11
Not known 175 10 1 1 2 1 1 2 0 0 1 194
Total for gas fuels 781 50 38 46 46 38 34 29 28 41 23 1154
Aerosols
Directly into mouth 40 1 0 0 0 1 0 3 4 1 1 51
Sniffed from container 10 0 1 0 1 2 0 0 0 0 1 15
Sniffed from cloth or sleeves 71 1 5 7 6 1 2 3 2 1 2 101
Sniffed from plastic bag 62 3 0 2 1 0 1 0 1 0 0 70
Plastic bag over head 33 2 3 0 0 0 1 1 0 3 0 43
Mask or padding over face 10 0 0 0 0 0 0 0 0 0 0 10
Other 2 0 0 0 0 0 0 0 0 0 0 2
Not known 83 3 4 3 2 1 0 1 0 0 0 97
Total for aerosols 311 10 13 12 10 5 4 8 7 5 4 389
Glues
Directly into mouth 6 0 0 0 0 0 0 0 0 0 0 6
Sniffed from container 13 2 1 0 1 1 2 1 0 0 0 21
Sniffed from cloth or sleeves 3 0 0 0 0 0 0 0 0 0 0 3
Sniffed from plastic bag 146 2 1 1 2 1 0 0 0 0 0 153
Plastic bag over head 44 0 1 0 0 0 3 0 0 0 0 48
Mask or padding over face 6 0 0 0 0 1 0 0 0 0 0 7
Other 1 0 0 0 0 0 0 0 0 0 0 1
Not known 76 1 3 3 0 1 0 1 1 0 0 86
Total for glues 295 5 6 4 3 4 5 2 1 0 0 325
Others
Directly into mouth 19 0 0 0 0 0 0 0 1 0 0 20
Sniffed from container 81 1 0 0 3 3 2 2 2 3 0 97
Sniffed from cloth or sleeves 95 2 0 0 1 3 0 0 2 0 3 106
Sniffed from plastic bag 36 2 1 0 0 0 0 0 0 0 1 40
Plastic bag over head 37 1 3 0 1 1 1 3 8 2 2 59
Mask or padding over face 14 1 2 1 0 0 2 2 2 7 3 34
Other 11 0 0 0 0 0 0 0 0 0 0 11
Not known 100 3 3 0 1 0 0 0 0 1 0 108
Total for others 393 10 9 1 6 7 5 7 15 13 9 475
Note: Other includes fire extinguisher and substance not known
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Mechanism of death
VSA causes death either as a result of a direct
toxic mechanism or as a result of other indirect
mechanisms including plastic bag asphyxia,
inhalation or aspiration of stomach contents,
and trauma. Where there is a possibility of an
indirect mechanism this is given priority,
otherwise the death is recorded as due to
‘direct toxic effects’.
Table 12 and Figure 12 show the numbers of
deaths due to each mechanism. The majority of
deaths (71% overall and 81% in 2008) are due
to direct toxic effects. Between 2004 and 2006
there was an increase in the proportion of
deaths associated with asphyxiation, mainly by
plastic bag, followed by a decrease. The
proportion of trauma deaths, which historically
were more common with the abuse of glue, has
largely decreased over time, from an average of
7% (1999-2003) to an average of 3% (2004-
2008).
Table 12: Principal mechanism of death for all ages, 1999-2008
YearMechanism
99 00 01 02 03 04 05 06 07 08
Total
Direct toxic effect 51 40 48 44 43 32 30 38 44 29 399
% 68.0 60.6 76.2 67.7 79.6 66.7 65.2 74.5 74.6 80.6 70.9
Asphyxia-mainly
plastic bag
6 8 2 6 2 9 8 11 10 5 67
% 8.0 12.1 3.2 9.2 3.7 18.8 17.4 21.6 16.9 13.9 11.9
Inhalation of vomit 8 6 10 9 6 5 3 1 2 0 50
% 10.7 9.1 15.9 13.8 11.1 10.4 6.5 2.0 3.4 0.0 8.9
Trauma 6 9 3 3 1 1 4 1 1 0 29
% 8.0 13.6 4.8 4.6 1.9 2.1 8.7 2.0 1.7 0.0 5.2
Other 0 1 0 0 0 1 1 0 1 1 5
% 0.0 1.5 0.0 0.0 0.0 2.1 2.2 0.0 1.7 2.8 0.9
Not known 4 2 0 3 2 0 0 0 1 1 13
% 5.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.3
Total 75 66 63 65 54 48 46 51 59 36 563
Previous history of solvent abuse
In 2008, for 16 of the 36 VSA deaths (44%)
there was evidence of a previous history of
solvent abuse; for the remaining 56%, there was
no evidence of previous volatile substance
abuse, or the history was unknown. However,
an absence of evidence should not lead to the
assumption that death occurred on the first
occasion, as this fact is often difficult to
establish.
Place of fatal abuse and death
Figure 13 shows where the fatal abuse leading
to death took place. In 2008 the most common
place for abuse remained the abuser’s home
(86%), followed by 8% of abuses in a public
place such as a park, shopping centre or the
street; place of work. Abuse in other places
accounted for 6%. There were no deaths at
the home of a friend.
Figure 14 shows the place of fatal abuse by
gender for the period 1999-2008. There was a
weak statistically significant difference between
males and females in the place of fatal abuse
(X2=7.3, 6 df, p<0.10).
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Figure 12: Principal mechanism of VSA death for all ages,
1999-2008
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Figure 13: Place of fatal abuse, 2008 (n=36)
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Figure 14: Place of fatal abuse by gender, 1999-2008
(n=563)
Male (n=453) Female (n=110)
The relationship between age and place of
fatal abuse is shown in Table 13. Looking at
the last ten years, the most common place of
fatal abuse was the person’s home or the
home of a friend. This proportion for the age
less than 18 years dying at home or the home
of a friend was 61% and for the 18 years and
over was 82%.
Figure 15 shows the place of VSA death in
2008. Three-quarters (75%) of deaths occurred
at home and 17% of deaths were recorded as
having occurred in hospital, or as ‘dead on
arrival’ at hospital. There was no death in the
home of a friend.
Table 13: Place of fatal abuse by age-group, 1999-2008
Place of abuse
Home Home of
friend
Public
place
Other
places
TotalAge-group
(Year)
No. % No. % No % No % No
< 10 1 100.0 0 0.0 0 0.0 0 0.0 1
10-14 18 42.9 3 7.1 20 47.6 1 2.4 42
15-19 87 56.9 15 9.8 42 27.5 9 5.9 153
20-24 63 75.0 6 7.1 12 14.3 3 3.6 84
25-44 176 79.6 8 3.6 27 12.2 10 4.5 221
45+ 53 85.5 1 1.6 3 4.8 5 8.1 62
< 18 72 50.7 15 10.6 50 35.2 5 3.5 142
18+ 326 77.4 18 4.3 53 12.8 23 5.5 421
All ages 398 70.0 33 5.9 104 18.5 28 5.0 563
VSA
International Centre for Drug Policy 26
Figure 15: Place of VSA death, 2008 (n=36)
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Suicide
Information on deaths since 1999 associated
with the inhalation of a volatile substance
where there was an inquest verdict or
Procurator Fiscal finding of suicide is provided
in this report. It is sometimes difficult to
establish for suicides, particularly where no
‘suicide note’ is left (or found), what influence
the inhalation of a volatile substance had on
the actions of the deceased. The use of a
volatile substance in combination with a plastic
bag over the head often results in death by
asphyxiation, which may be the intended
result. However, it has be remembered that
plastic bags can also be used to heighten
sexual experience and thus death may be the
result of an accident arising from impaired
judgement due to lack of oxygen and/or the
effects of psychoactive (including volatile)
substances.
Table 14: Number of suicides associated with a volatile substance, 1999-2008
Suicide TotalYear
Male Female Suicide VSA
% of VSA
deaths
Median age
at death
1999 6 0 6 75 8.0 56
2000 3 0 3 66 4.5 38
2001 4 0 4 63 6.4 42
2002 4 2 6 65 9.2 48
2003 3 1 4 54 7.4 45
2004 3 0 3 48 6.3 53
2005 6 3 9 46 19.5 36
2006 8 2 10 51 19.6 42
2007 9 0 9 59 15.2 36
2008 4 0 4 36 11.1 44
Total 50 8 58 563 10.3 36
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Table 14 gives the frequency and median age at
death by year, and Figure 17 shows the age-
and gender-distribution of suicides involving
VSA. In 2008 there were four suicides
associated with the inhalation of a volatile
substance. This is lower than the level in 2007,
and even lower than in the previous two years.
To put these figures in perspective, it is worth
mentioning that the total (adults aged 15 years
and over) number of suicides (defined using
ICD-9 and ICD-10 codes) recorded in the UK
from 1999-2008 by the General Register Offices
was 58,026 with a male:female ratio of 3:1
(Personal communication to the Project from
ONS, 2010).
For suicides associated with the inhalation of a
volatile substance, a continuous decrease in the
median age was found over time (1999-2008),
with an exception in 2004. The median age of
suicide was 56 years in 1999, which fell to 41
years in 2006-8. For all suicides involving VSA
since 1999, the male-female differences are
more pronounced in different age-groups,
particularly in those aged 20 and above (see
Figure 16).
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Figure 16: Age- and gender-distribution of suicides
associated with volatile substances, 1999-2008 (n=58)
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Deaths associated with helium: an early warning
Whilst inert gases, like helium and nitrogen, do
not strictly come under the definition of volatile
substances this report series has included
reference to helium-related deaths since 1999.
The cylinders of helium that can be used for
inflating balloons are easily available from
party shops, and to purchase over the Internet.
It has become evident to the team that, in the
last couple of years, there has been a rapid
increase in the number of deaths, including
suicides, resulting from the deliberate inhalation
of helium.
This part of the report presents a brief overview
of deaths resulting from the deliberate inhalation
of helium gas between 2001 and 2008. Figure
17 gives the number of such deaths during this
period; the total number of such deaths in this
period was 64, of which 25 occurred in 2008.
The majority (89%) of the deaths were suicides,
with the remaining 8 cases (11%) being
regarded as of undetermined intent, e.g. open
verdict.
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Figure 17: Distribution of deaths associated with
inhalation of helium, 2001-2008
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Table 15 shows the distribution of deaths
associated with helium inhalation by age-group
and gender. In 2008, there were 25 cases
identified of those who committed suicide by
inhalation of helium while these were 39 cases
(61%) during the previous seven years (2001-
07). Overall, the majority 80% were male, this
percentage unchanging over time. Deaths were
more pronounced among the 20-39 years age-
group as compared to other age-groups shown
in Table 15.
Figure 18 shows causes of death due to
inhalation of helium between 2001 and 2008.
The majority of deaths were caused by
asphyxia, including plastic bag over the head,
due to inhalation of the gas.
The monitoring by this project of deaths
involving the deliberate inhalation of gases and
vapours has allowed the identification of a rapid
increase in deaths resulting from the use of
helium. This figure is particularly pronounced
between 2007 and 2008, and appears to
principally involve suicides. Early indications
show that this trend is continuing.
Table 15: Age- and gender distribution of deaths due to helium inhalation
2001-6 2007 2008Age group
Male Female Male Female Male Female
< 20 years 0 1 0 0 1 0
% 0.0 16.7 0.0 0.0 5.0 0.0
20-39 13 3 4 0 9 2
% 56.5 50.0 50.0 0.0 45.0 40.0
40-59 7 2 3 1 9 3
% 30.4 33.3 37.5 50.0 45.0 60.0
60 & above 3 0 1 1 1 0
% 13.0 0.0 12.5 50.0 5.0 0.0
All ages 23 6 8 2 20 5
% 100.0 100.0 100.0 100.0 100.0 100.0
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Figure 18: Causes of death due to helium inhalation, 2001-2008
Asphyxia
Poisoning by/ Intoxication
Inhalation of helium
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Commentary
The purpose of this Project is to monitor trends
in deaths associated with the abuse of volatile
substances. This report reports on those trends
rather than providing an exhaustive
commentary. The results presented here
indicate that there has been a significant
overall decline in deaths from volatile
substance abuse in the United Kingdom since
1992. However, efforts to educate people on
the dangers of inhalation of volatile
substances should continue, especially since
young people are at greater risk of dying from
VSA than from drug misuse or other causes of
death. Although helium is not a volatile
substance, monitoring of this gas shows an
increasing trend in suicide from helium
inhalation. Consideration may need to be given
to raising awareness of this issue.
Overall, the patterns of death associated with
VSA in the UK remained fairly stable in 2008.
This was true, especially in respect of the
products and substances abused the place of
death, as well as the age- and gender-
distributions. However, the main change was a
decline in the number of deaths from 59 to 36,
the lowest since 1980.
This notable decline in deaths between 2007
and 2008 would appear to be an actual decline
rather than the result of changes in the project
personnel. Case-ascertainment methods have
remained consistent with previous years and,
if anything, made more robust through greater
triangulation of sources and the use of
additional information flows. It is possible that
the decline in deaths between 2007 and 2008
may be due to falls in the following types of
fatalities:
 Deaths among those aged 25 years and
over;
 Deaths associated with gas fuels,
especially lighter fuel and butane gas
cans;
 Accidental deaths; and
 Deaths due to the direct toxic effects of the
inhaled substances, including plastic bag
asphyxia.
However, this large fall in deaths from one year
to another should be seen as part of a longer-
term downward trend. This becomes clearer
when special statistical techniques are applied,
as discussed elsewhere in this report. It may be
that, as in some previous years, further deaths
that occurred in 2008 will be notified
retrospectively by coroners as their inquiries are
completed.
Data for recent years suggests that one-third of
deaths associated with volatile substance
abuse still occur amongst those aged under-
20 years, predominantly among males. More
than half of these premature fatalities are
accidental in nature. Therefore, it is important
to initiate public health strategies to prevent
the risk of accidental death for those abusing
volatile substances. In a high proportion (69%)
of such deaths in 2008 other psychoactive
substances, including alcohol was found to be
present at post mortem. These findings
underline the continuing emergence of
polysubstance abuse and the potentially fatal
role in death of combining such substances.
Suicide rates associated with the inhalation of a
volatile substance have fallen steadily, yet
continue to occur predominantly amongst
males. This decline may be due, in part, to an
increase in the number of deaths involving the
deliberate inhalation of helium, particularly in
recent years. It should be possible to reduce the
number of suicides using volatile substances
and gases if the availability and accessibility of
such substances were more restricted. There is
evidence that the introduction of legislation has
had no effect on the availability of products such
as butane gas lighter refills (Esmail et al, 1992).
If safer alternatives were in the market, there
would be fewer and less easily accessible
substances for committing suicide.
This report documents, for the first time
anywhere, an emerging issue of an increasing
number of suicides due to deliberate helium
inhalation. The numbers more than tripled
between 2006 and 2008, and appears to
principally involve suicides. Early indications
show that this trend is continuing. Those who
committed suicide by inhalation of helium were
mainly adult males, including those of aged
20-39 years. This phenomenon merits further
detailed research.
Deaths involving nitrous oxide and nitrites are
still occurring, albeit at low levels. These still
need to be monitored closely, as they are
more frequent than in previous decades.
This report, as well as demonstrating what has
happened in 2008 and previous years in terms
in respect of deaths involving volatile
substances, also provides an indication of
possible evolving changes in use patterns, and
newly-emerging issues.
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Appendix
Description and examples of commonly abused volatile substances and solvents
This is not meant to be an exhaustive list, but it does give some examples of the substances
typically abused in the UK.
Type Description Examples
Aerosols Sprays containing propellants and solvents Contact adhesives
Hairsprays
Fabric protector sprays
Insect sprays
Spray paints
Vegetable oil sprays
Gases Medical anaethestics
Gases used in household or commercial
products
Chloroform, ether, halothane,
nitrous oxide (laughing gas)
Butane lighters, butane/
propane canisters, whipped
cream dispensers, refrigerants,
and home carbonation
systems for soft drinks.
Nitrites ‘Poppers’ act primarily to dilate blood
vessels and relax muscles, unlike most
other volatile substances which are used to
alter mood. Nitrites are used chiefly to
enhance sexual experiences.
Amyl nitrite, butyl nitrite
Volatile solvents Liquids that vaporise at room temperature.
Contained in a range of cheap, easily
available products used for normal
domestic and industrial purposes
Paint thinners and removers
/strippers
Dry-cleaning fluids
Degreasers
Petrol and petroleum products
Glues
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